Pedigree

World-class tech for real world clinics.

20+ years of innovation & development. Built from a passion to bring ultra-high resolution (UHR) spectral imaging out of foundational science and into the hands of everyday clinicians. In the same city where Sir Ernest Rutherford conducted early research that later contributed to the discovery of the nucleus, MARS Bioimaging has made the ground-breaking CERN technology inside Medipix3RX photon-counting detectors available for advanced medical imaging across the pathway.

About MARS Bioimaging

Use of Medipix3RX is licensed to MARS Bioimaging for use in medical imaging.
CERN does not endorse any products or companies. Prof. Phil Butler, Founder Director, pictured beside Prof. Anthony Butler.

Spectrasight technology
Placeholder
“Image where the patient is; when they need it; with the test they most need.”
Prof. Anthony Butler • Founder & CTO
MARS Bioimaging, SpecXray 2026